Meitheal Gets US Enoxaparin Approval
NKF-Controlled Meitheal Makes Progress With Lovenox Rival
Through its partnership with majority stakeholder Nanjing King-Friend Biochemical Pharmaceutical, Meitheal Pharmaceuticals has received FDA approval for enoxaparin, a generic rival to Lovenox.
